Emerging role of Alzheimer's disease-associated ubiquilin-1 in protein aggregation

Biochem Soc Trans. 2010 Feb;38(Pt 1):150-5. doi: 10.1042/BST0380150.

Abstract

Abnormal protein aggregation and intracellular or extracellular accumulation of misfolded and aggregated proteins are key events in the pathogenesis of different neurodegenerative diseases. Furthermore, endoplasmic reticulum stress and impairment of the ubiquitin-proteasome system probably contribute to neurodegeneration in these diseases. A characteristic feature of AD (Alzheimer's disease) is the abnormal accumulation of Abeta (amyloid beta-peptide) in the brain. Evidence shows that the AD-associated PS (presenilin) also forms aggregates under certain conditions and that another AD-associated protein, ubiquilin-1, controls protein aggregation and deposition of aggregated proteins. Here, we review the current knowledge of ubiquilin-1 and PS in protein aggregation and related events that potentially influence neurodegeneration.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Amyloid beta-Peptides / metabolism
  • Autophagy-Related Proteins
  • Carrier Proteins / chemistry
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Cell Cycle Proteins / chemistry
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism*
  • Endoplasmic Reticulum / metabolism
  • Humans
  • Inclusion Bodies / metabolism
  • Oxidative Stress
  • Presenilins / metabolism
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Conformation
  • Protein Folding

Substances

  • Adaptor Proteins, Signal Transducing
  • Amyloid beta-Peptides
  • Autophagy-Related Proteins
  • Carrier Proteins
  • Cell Cycle Proteins
  • Presenilins
  • UBQLN1 protein, human
  • Proteasome Endopeptidase Complex